Piprinhydrinate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H23NO.C7H7ClN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SI78RFJ7XI, chemically known as theophylline, 8-chloro-, compd. with 4-(diphenylmethoxy)-1-methylpiperidine (1:1) but generally known as piprinhydrinate, which bears US NIH Compound Identifier 71640. European Medicines Agency schedules Piprinhydrinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09886MIG. The term PIPRINHYDRINATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). PIPRINHYDRINATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piprinhydrinate under HS 29395900 and SITC 54145. As of Q4 2014, PIPRINHYDRINATE remains the US FDA Preferred Term for this commodity. Piprinhydrinate bears US NLM identifiers UMLS ID C0771945 and NCI Concept Code C66408. SMILES: CLC1[NH]C2C(N(C(=O)N(C2=O)C)C)N1.O(C1CCN(CC1)C)C(C1CCCCC1)C1CCCCC1.